(Press-News.org) In a research article published April 3 in the online, open-access journal PLoS Biology, Prof. Sylvia Cremer and colleagues at the Institute of Science and Technology, Austria show how micro-infections promote social vaccination in ant societies. Like crowded megacities, ant colonies face a high risk of disease outbreaks. These are kept in check by the ants' social immune system—a set of collective hygienic behaviours and adaptive changes in interaction frequencies that acts in conjunction with the physiological, innate immune system of colony members. Prof. Cremer and colleagues now unravel how taking care of sick ants promotes disease protection in their group members. They also discuss their findings in the latest edition of the PLoS Podcast (http://blogs.plos.org/plospodcasts/).
Ants do not avoid sick colony members, but lick them to remove the pathogen from the exposed ant's body. This social grooming behaviour drastically increases the survival chances of exposed individuals, but bares the risk that helper ants contract the disease. By applying fluorescence-labelled fungal spores to some ants and allowing them to interact with healthy colony members, the researchers showed that the labelled spores spread throughout the colony. Interestingly, however, spore transfer occurs at very low levels, causing only sub-lethal micro-infections in the previously healthy colony members. The authors determined that these low-level infections induce the expression of a specific set of immune genes and increase the ants' capacity to fight the fungal pathogen. Additional mathematical modelling suggests that such social immunization enables colonies to recover more rapidly from an infection, providing new clues into its evolutionary significance.
Social low-level spread of infectious particles therefore constitutes the underlying mechanism of social immunisation against fungal infections in ant societies. This is nature's counterpart to the first human efforts in inducing immunity against deadly diseases like smallpox. At a time when vaccination with dead or attenuated strains was not yet invented, immunity was induced in people by actively transferring low-level infections through so-called variolation. The extent of any human implications is not yet clear, but this study allows for informed inferrences to be made for a wider context.
As Simon Babyan from Edinburgh University and David Schneider from Stanford note in an accompanying primer article also published in PLoS Biology, "The authors used a combination of approaches to identify the mechanisms underlying social immunisation in ant colonies: mathematical modelling, behavioural, microbiological, immunological and molecular techniques, which, taken together, offer an exciting proof-of-concept that group-level immunity may be experimentally manipulated and modelled… By studying social immunity at a system level in insects perhaps we can find emergent properties that we have been missing in another important social animal—the human."
### Funding: Funding for this project was obtained by the German Research Foundation DFG (http://www.dfg.de/en/index.jsp) as an Individual Research Grant (CR118/2-1 to SC) and the European Research Council (http://erc.europa.eu/) in form of two ERC Starting Grants (ERC-2009-StG240371-SocialVaccines to SC and ERC-2010-StG259294-LatentCauses to FJT). In addition, the Junge Akademie (Young Academy of the Berlin-Brandenburg Academy of Sciences and Humanities and the National Academy of Sciences Leopoldina (http://www.diejungeakademie.de/ english/index.html) funded this joint Antnet project of SC and FJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Citation: Konrad M, Vyleta ML, Theis FJ, Stock M, Tragust S, et al. (2012) Social Transfer of Pathogenic Fungus Promotes Active Immunisation in Ant Colonies. PLoS Biol 10(4): e1001300. doi:10.1371/journal.pbio.1001300
CONTACT:
Sylvia Cremer
IST Austria (Institute of Science and Technology)
Am Campus 1
Klosterneuburg, 3400
AUSTRIA
Tel: 43-2243-9000-3401
sylvia.cremer@ist.ac.at
How social contact with sick ants protects their nestmates
2012-04-04
ELSE PRESS RELEASES FROM THIS DATE:
Anago Cleaning Systems Hosts Annual Master Franchise Conference in Orlando
2012-04-04
Top executives at Anago Cleaning Systems hosted its 2012 annual conference for their Master Franchisees in an effort to celebrate major growth and successes in 2011, and prepare for aggressive expansion and improvement throughout each territory and the nation. New and existing Master Franchisees alike attended the two-day show that was held on March 5-6, 2012 in Orlando, Florida.
The convention kicked off with opening remarks from Anago Cleaning Systems Founder, David Povlitz.
Mr. Povlitz reiterated that the vision, mission, and values of the company he founded in ...
Researchers use a game to change how scientists study outbreaks
2012-04-04
An international team of scientists has created an innovative tool for teaching the fundamentals of epidemiology—the science of how infectious diseases move through a population.
The team teaches a workshop annually in South Africa that helps epidemiologists improve the mathematical models they use to study outbreaks of diseases like cholera, AIDS and malaria. Led by Steve Bellan from the University of California at Berkeley, the team created a new game as a teaching aid for the workshop. The exercise, which has proven extremely effective in demonstrating concepts in ...
How do cancers become resistant to chemotherapy?
2012-04-04
Genetic mutations in cancer cells can lead to resistance to treatment, thereby potentially resulting in relapse. However, a new article, published April 3 in the magazine section of the online, open-access journal PLoS Biology, suggests that the converse may also happen. Steven Frank from the University of California, Irvine, and Marsha Rosner from the University of Chicago, propose that it may often be the case that a few cells become resistant before any genetic change, and then later acquire the genes to stabilize that resistance.
Why does it matter whether resistance ...
First New England SalesPad Software User Group Hosted by Connecticut Dynamics GP Partner CAL Business Solutions
2012-04-04
CAL Business Solutions, a Connecticut based Microsoft Dynamics GP partner, today announced that it will host the first ever New England SalesPad user group workshop. Companies using Microsoft Dynamics GP with SalesPad, an add on product for the distribution industry, will have the opportunity to come together to see new features, share ideas, network with their peers and provide input on future product developments.
The user group will be held at the Crowne Plaza hotel in Cromwell, Connecticut from 8:00-11:30am on Monday May 7th. Topics on the agenda include advanced ...
New hormone for lowering blood sugar
2012-04-04
New evidence points to a hormone that leaves muscles gobbling up sugar as if they can't get enough. That factor, which can be coaxed out of fat stem cells, could lead to a new treatment to lower blood sugar and improve metabolism, according to a report in the April issue of Cell Metabolism, a Cell Press publication.
This new fat-derived hormone would appear to be a useful alternative or add-on to insulin; it can do essentially the same job, sending glucose out of the bloodstream and into muscle.
"It's like you've opened the door and now the glucose can come in," said ...
Strong and consistent evidence supports low-energy-density diets for weight loss
2012-04-04
Philadelphia, PA, April 3, 2012 – A new report published online today in the Journal of the Academy of Nutrition and Dietetics systematically reviews and updates the evidence underlying the recommendation in the Dietary Guidelines for Americans 2010 to consume a diet low in energy density (ED). The report addresses the growing body of evidence linking ED, or the number of calories in a given amount of food, and body weight in adults as well as children and adolescents. The systematic review concluded that there is strong and consistent evidence in adults showing that consuming ...
How a cancer drug leads to diabetes
2012-04-04
The drug known as rapamycin is widely used by cancer and transplant patients, and there are hints that it might even help us put off old age and live longer. But, it also comes with a downside: rapamycin leads to diabetes in as many as 15 percent of the people who take it.
Now, researchers reporting in the April Cell Metabolism, a Cell Press publication, have figured out why that is. The drug turns the insulin signal off in muscle, to prevent muscle cells from taking blood sugar in.
"This is a drug that is pretty well known for its benefits," said Pere Puigserver ...
Researchers discover a DNA marker that indicates if ovarian cancer treatment will be successful
2012-04-04
CHICAGO, IL – Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer. More specifically, a genetic marker embedded in deoxyribonucleic acid (DNA), called microRNA, indicates if a patient with ovarian cancer has a benign or cancerous tumor, and that she will benefit from chemotherapy after surgery on the tumor. This data will be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held ...
Researchers reveal why some pain drugs become less effective over time
2012-04-04
MONTREAL, April 3, 2012 – Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells like those in our bodies are able to build up resistance to opioid pain drugs within hours. Humans have known about the usefulness of opioids, which are often harvested from poppy plants, for centuries, but we have very little insight into how they lose their effectiveness in the hours, days and weeks following the first dose. "Our study revealed cellular and molecular mechanisms within our bodies that enables us to develop resistance to this medication, ...
Southampton research could lead to better treatments for cardiovascular disease
2012-04-04
Scientists at the University of Southampton have discovered a new process that controls the ability of arteries to regulate blood pressure.
Arteries are able to control blood pressure by relaxing and constricting. In healthy people, the ability of arteries to relax or constrict is kept in balance. However, this balance shifts in people who are at risk of developing high blood pressure or atherosclerosis. There is more constriction within the arteries so blood cannot flow freely increasing the risk of heart attacks and stroke.
Researchers in Southampton, led by Dr ...